Approved Study Database

Ref. No. Scientific Title Principal investigator
2015.235 Development and Dissemination of an Online Exercise and Health Promotion Program for Hong Kong Middle-aged Chinese: The Virtual Trainer System 3rd Version Prof. HUI Stanley Sai Chuen
許世全
2016.198 Effects of a 7-minute Exercise Invention that Integrates Interactive Website, mobile Apps and Movement Detection Device in Hong Kong School Students Dr. HUI Stanley
HUI Sai-chuen
2017.105 Tai Chi versus Walking in Promoting Mental Health in Adults Prof. HUI Stanley
HUI Sai-chuen
2012.372 Cardiovascular risks in people witih multiple skin tags: a multicenter case-control study Dr HUI Siu Yan Edith
2019.591 Preliminary study on the effectiveness of self-management educational program on patients with osteoporotic vertebral fracture suffering from chronic back pain Ms. HUI Sin Ting
許倩婷
2008.333 An Observational Study on Prevalence of Hydronephrosis in Patients with Pelvic Organ Prolapse Dr Hui Shuk Yi Annie
2012.256 Trends in preterm birth and perinatal mortality rates in Hong Kong, 1995 through 2011 Dr Hui Shuk Yi Annie
2008.349 Randomized Study of Pessary versus Expectant Management in Twins Dr Hui Shuk Yi Annie
2008.375 Randomized Study of Pessary versus Expectant Management Among Women with A Short Cervix in Singleton Pregnancy Dr Hui Shuk Yi Annie
2020.461 The causes and timing of maternal mortality in Hong Kong – what have we missed? Dr. HUI Shuk Yi
許淑儀
2020.098 Evaluation of risk factors associated with immunoprophylaxis failure of pregnant hepatitis B carriers in Hong Kong Dr. HUI Shuk Yi
許淑儀
2008.517 A Randomised, Double-blind, Double-dummy, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of 48 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (5µg [2 actuations of 2.5 µg] and 10 µg [2 actuations of 5 µg]) Delivered by the Respimat® Inhaler, and 48 Weeks of Twice Daily Foradil® (12 µg) Delivered by the Aerolizer® Inhaler, in Patients with Chronic Obstructive Pulmonary Disease (COPD) Professor Hui Shu Cheong, David
2012.491 An observational, multi-center, prospective, open-label study to assess the real-life treatment pattern for Chronic Obstructive Pulmonary Disease (COPD) in Hong Kong and its adherence to GOLD guideline Prof Hui Shu Cheong David
2010.572 A Phase III international, randomized, double-blind, double-dummy study to evaluate the efficacy and safety of 300 mg or 600 mg of intravenous zanamivir twice daily compared to 75 mg of oral oseltamivir twice daily in the treatment of hospitalized adults and adolescents with influenza Prof. Hui Shu Cheong David
2012.076 A randomized controlled study on the effects of CPAP on visceral fat thickness, carotid intima-media thickness and adipokines in patients with Obstructive Sleep Apnoea Syndrome Prof Hui Shu Cheong David
2021.037 A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS Prof. HUI Shu Cheong David
許樹昌教授
2025.143 Chest X-ray Artificial Intelligence Assistance for Radiologist - A Proof of Concept Prof. HUI Sai Kam
2019.205 The Effects of a Combined Acute and Chronic Aerobic Exercise Program on Autonomic and Cognitive Functions with Acute Psychological Stress Prof. HUI Sai Chuen
許世全
2018.508 Development and validation of a risk model integrating post-radiotherapy plasma Epstein-Bar virus DNA and TNM stage for stratification of nasopharyngeal cancer to adjuvant therapy Dr. HUI Pun
許斌
2009.627 Association between Physical Activity Knowledge, Physical Activity Behavior, and Age in Hong Kong Chinese Adults with Type 2 Diabetes Dr Hui Pui Sze Grace
2014.223 The Association between Black Carbon/Ground-level Ozone and Acute Respiratory Effects in Healthy Young Adult Cyclists- A Crossover Study in Hong Kong Miss HUI Nga Ting
2012.203 The validation of the screening programme for diabetic retinopathy Dr Hui Ming Tung Eric
2017.294 Retrospective analysis of Candida parapsilosis complex fungaemia. Dr. HUI Mamie
許明媚
2025.080 Comparison of suicidal fall and accidental fall patient characteristics in fall from height patients Dr. HUI Lok Hin
2019.492 A study on the view of Hong Kong parents on secondary use of dried blood spots in newborn screening program - implications on evidence-based policies Dr. HUI Lai Ling
許麗玲
2019.616 Economic evaluation on breastfeeding promotion in Hong Kong Dr. HUI Lai Ling
許麗玲
2017.456 A Retrospective Evaluation of the use of Crisis Packs in Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease in a local hospital Mr. HUI Kei Shing
許基誠
2011.319 Knowledge, Attitude and Practice of Chronic Disease Patient on Counterfelt Drugs buying in Hong Kong Mr Hui Ka Chun
2013.132 Glycogen Storage Disease Type 1 in Hong Kong: diagnosis, clinical course and outcome Dr Hui Joannie
2016.567 International Network on Neurotransmitter related Disorder (iNTD) Registry Dr. HUI Joannie
許鍾妮
2015.098 Rare Disease Registry Program Dr. HUI Joannie
2016.055 In-depth study of the cost-effectiveness of the Risk Assessment and Management Programme for Hypertension (RAMP-HT) for patients with uncontrolled hypertension in primary care in Hong Kong Dr. HUI Eric Ming Tung
許明通
2013.423 Evaluation of Quality of Care : Risk Assessment and Management Programme - Hypertension, Hospital Authority Dr. HUI Eric Ming Tung
2020.337 Development and validation of HA electronic Frailty Index (HA-eFI) Dr. HUI Elsie
許鷗思
2007.101 Immune Responses in Nasopharyngeal Carcinoma Dr. HUI Edwin Pun
2011.257 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy Dr. HUI Edwin Pun
2008.131 A Multi-center Study of the Therapeutic Role of Continuous Positive Airway Pressure Therapy on Ischemic Stroke Survivors with Obstructive Sleep Apnoea Syndrome Prof Hui David Shu-Cheong
2013.213 A 52-week treatment, multi-center, randomized, double-blind, double dummy, parallel-group, active controlled study to compare the effect of QVA149 (indacaterol maleate / glycopyrronium bromide) with salmeterol/fluticasone on the rate of exacerbations in subjects with moderate to very severe COPD Prof. HUI David Shu Cheong
2011.215 A randomized controlled study assessing the role of an ambulatory approach versus the conventional approach in managing moderate to severe obstructive sleep apnoea syndrome Prof Hui David Shu Cheong
2011.470 A Phase III, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate Compared with Aclidinium Bromide, Formoterol Fumarate and Placebo for 24 Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) Professor Hui David Shu Cheong
2010.266 A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 50 years and older Prof. HUI David Shu Cheong
2010.267 A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 70 years and older Prof. HUI David Shu Cheong
2008.286 A Randomized, Parallel, Controlled Study to Evaluate the Role of Pretreatment Drug Susceptibility Tests in the Selection of Regimens of Chemotherapy for Retreatment of Relapsed Pulmonary TB in Guangzhou Prof Hui David Shu Cheong
2010.605 A 6-month, double-blind, randomised, multicenter, multinational trial to investigate the effect of 500 Professor Hui David Shu Cheong
2011.214 The effects of CPAP on twist mechanics of the left ventricle in patients with moderate to severe Obstructive Sleep Apnoea Prof Hui David Shu Cheong
2007.072 Management and Clinical Progress of Patients with Severe Influenza - A Prospective Observational Study Prof. HUI David Shu Cheong
2014.417 A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease Prof. HUI David Shu Cheong
2014.334 Randomized, double-blind, placebo-controlled, multicenter study comparing Ciprofloxacin DPI 32.5 mg BID intermittently administered for 28 days on / 28 days off or 14 days on / 14 days off versus placebo to evaluate the time to first pulmonary exacerbation and frequency of exacerbations in subjects with non-cystic fibrosis bronchiectasis Prof. HUI David Shu Cheong
2016.191 A phase IIIb, open-label, multi-country, multi-centre, long-term follow-up study (ZOE-LTFU) of studies 110390 and 113077 (ZOSTER-006/022) to assess the prophylactic efficacy, safety, and immunogenicity persistence of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine and assessment of 1 or 2 additional doses on a 0 or 0, 2-month schedule in two subgroups of older adults. Prof. HUI David Shu Cheong
許樹昌
2014.640 A randomised, double-blind, active-controlled parallel group study to evaluate the effect of 52 weeks of once daily treatment of orally inhaled tiotropium + olodaterol fixed dose combination compared with tiotropium on Chronic Obstructive Pulmonary Disease (COPD) exacerbation in patients with severe to very severe COPD. Prof. HUI David Shu Cheong

Page 158 of 262.